Simmerman Law Office PLLC

West Virginia

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases31

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechMech Eng, ManufChemical

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/16/24	Regeneron Pharmaceuticals Inc v. Samsung Bioepis Co Ltd 1:23-CV-00094 ( N.D. WV )	ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024)
09/06/24	Bayer Pharma AG v. Mylan Pharmaceuticals Inc 1:21-CV-01742 ( D. DE )	Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024)
07/16/24	1:24-MD-03103 ( N.D. WV )	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 258 in 1:24-md-03103-TSK-JPM and 268 in 1:23-cv-00094-TSK-JPM. Notice of Appeal filed by Samsung Bioepis, CO., LTD. Federal Circuit USCA Case Number: 2024-2083. (snc) (Entered: 07/16/2024)
07/16/24	1:24-MD-03103 ( N.D. WV )	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 250 in 1:23-cv-00106-TSK-JPM and 259 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-2082. (snc) (Entered: 07/16/2024)
07/16/24	Regeneron Pharmaceuticals Inc v. Samsung Bioepis Co Ltd 1:23-CV-00106 ( N.D. WV )	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 250 in 1:23-cv-00106-TSK-JPM and 259 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-2082. (snc) (Entered: 07/16/2024)
06/25/24	Actelion Pharmaceuticals Ltd v. Mylan Pharmaceuticals Inc 1:23-CV-00088 ( N.D. WV )	PROTECTIVE ORDER. Signed by Chief District Judge Thomas S Kleeh on 6/25/2024. (dk) (Entered: 06/25/2024)
07/25/23	Abraxis Bioscience LLC v. Mylan Pharma Inc 1:23-CV-00033 ( N.D. WV )	CONSENT JUDGMENT in favor of Abraxis Bioscience, LLC against Mylan Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 7/25/2023. (hrc) (Entered: 07/25/2023)
09/21/22	Bayer Pharma AG v. Mylan Pharma Inc 1:22-CV-00063 ( N.D. WV )	CERTIFIED COPY OF JPML CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) - 1 action(s) re: pldg. ( 29 in MDL No. 3017, 1 in WVN/1:22-cv-00063) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 9/21/2022. Associated Cases: MDL No. 3017, WVN/1:22-cv-00063. (dk) (Entered: 09/21/2022)
09/21/22	Bayer Pharma AG v. Mylan Pharma Inc 1:22-CV-00063 ( N.D. WV )	Case Transfer Complete - Case transferred to District of Delaware on 9/21/2022. District of Delaware's case number is 1:22cv01228. (dk) (Entered: 09/21/2022)
09/21/22	Bayer Pharma AG v. Mylan Pharma Inc 1:22-CV-00063 ( N.D. WV )	Case transferred to District of District of Delaware re MDL 3017. Entire Case file electronically transmitted. (dk) (Entered: 09/21/2022)